+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
DA2PP Vaccine Market - Global Forecast 2026-2032- Product Image
DA2PP Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

DA2PP Vaccine Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142793
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The DA2PP Vaccine Market is projected to reach USD 790.95 Million in 2026. It is expected to continue growing at a CAGR of 9.60%, reaching USD 1.37 Billion by 2032.

DA2PP Vaccine Market: Executive Overview

DA2PP vaccination protects dogs against distemper, adenovirus, parvovirus, and parainfluenza. Its role in preventive veterinary care is shaped by vaccination guidelines, veterinary access, animal ownership, public awareness, cold-chain reliability, and the ability of clinics and shelters to maintain reminder and follow-up systems. The market’s development therefore depends on both product availability and the broader organization of companion-animal health services.

Preventive Care Is Becoming More Structured and Data Driven

The landscape is shifting from isolated vaccination visits toward lifecycle-based preventive care. Veterinary practices increasingly use electronic records, automated reminders, risk assessments, and appointment protocols to improve adherence. At the same time, owners are paying closer attention to individualized schedules, travel requirements, shelter intake procedures, and the distinction between core and risk-based vaccination. Regulatory oversight, quality assurance, traceability, and professional education remain central to maintaining confidence in DA2PP immunization.

Artificial Intelligence Strengthens Adherence, Surveillance, and Operations

Artificial intelligence can support DA2PP vaccination programs by identifying overdue patients, prioritizing outreach, summarizing clinical histories, and detecting patterns in missed appointments or adverse-event reports. Computer-assisted decision tools may also help veterinarians combine age, prior vaccination, health status, exposure risk, and local epidemiological information when reviewing schedules. These applications require validated data, clinician oversight, privacy safeguards, transparent recommendations, and careful management of bias; AI should augment professional judgment rather than replace it.

Regional Insights: Access, Regulation, and Veterinary Infrastructure Differ

North America is characterized by established companion-animal practices, structured preventive-care reminders, and strong owner engagement, while Latin America reflects varied clinic access, household economics, and cold-chain capacity. Europe combines mature veterinary systems with detailed regulatory expectations, and the Middle East shows differing levels of urban veterinary concentration, import dependence, and pet-care awareness. Africa presents substantial variation between metropolitan and rural services, including challenges in distribution and follow-up. Asia-Pacific spans highly developed markets with sophisticated clinic networks and emerging systems where access, affordability, and professional capacity remain decisive.

Group Insights: Economic and Institutional Coordination Shapes Uptake

ASEAN markets reflect diverse regulatory systems, income levels, and veterinary infrastructure, making localized distribution and professional education important. BRICS countries combine large and varied companion-animal populations with differing manufacturing, import, and service environments. The European Union benefits from coordinated regulatory principles alongside national implementation differences. G7 countries generally have mature clinical information systems and established preventive-care practices. GCC markets are influenced by urban concentration, import logistics, and growing companion-animal services, while NATO members span varied health systems and regulatory settings that require country-specific execution rather than a single operating model.

Country Insights: Local Practice Patterns Determine Implementation

Australia and New Zealand-oriented veterinary models emphasize routine preventive care and geographic service coordination, while Brazil and Mexico require approaches suited to varied clinic access and regional income conditions. Canada, the United States, the United Kingdom, France, Germany, Italy, and Spain have established veterinary sectors, but differ in professional guidance, reminder practices, reimbursement, and owner behavior. China and India combine expanding companion-animal services with substantial regional variation in access and affordability. Japan and South Korea feature digitally capable, urban-focused veterinary environments. Russia’s implementation is shaped by regulatory conditions, supply continuity, and uneven service availability. Across all countries, local authorization, distribution, cold-chain management, and veterinarian-led communication are critical.

Action Priorities for Leaders in DA2PP Vaccination

Industry leaders should strengthen end-to-end quality systems, maintain dependable cold-chain and distribution processes, and align product information with current veterinary guidance. Partnerships with clinics, shelters, breeders, and public-health stakeholders can improve education and follow-up. Digital reminder systems should be interoperable with practice-management platforms and designed around consent and privacy. Organizations should segment outreach by geography, access barriers, animal life stage, and exposure risk, while monitoring completion, missed appointments, service quality, and safety signals through clearly defined governance processes.

Research Methodology for a Reliable Executive View

This executive summary uses the specified DA2PP vaccine market scope and organizes interpretation across product use, veterinary delivery, regulation, technology, geography, and stakeholder groups. Findings are framed from established principles of canine preventive medicine, veterinary service operations, cold-chain management, digital health governance, and regional market heterogeneity. No market estimates, shares, forecasts, or company-specific claims are used. Country and group observations are presented as contextual factors requiring validation against current national regulations, professional guidance, surveillance data, and local operating conditions.

Conclusion: Durable Growth Depends on Trust and Delivery Quality

The DA2PP vaccine market is fundamentally linked to reliable preventive-care systems rather than product availability alone. Sustainable progress depends on veterinarian-led communication, accessible services, consistent storage and handling, accurate records, and timely reminders. Regional and country differences make localized execution essential, while artificial intelligence can improve targeting and operational discipline when deployed responsibly. Leaders that combine clinical credibility, regulatory compliance, resilient delivery, and measurable follow-up will be best positioned to strengthen canine vaccination outcomes.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. DA2PP Vaccine Market, by Product Form
7.1. Introduction
7.2. Freeze-Dried
7.3. Liquid
7.3.1. Ready To Use
7.3.2. Reconstitutable
8. DA2PP Vaccine Market, by Application
8.1. Introduction
8.2. Booster Immunization
8.2.1. Multiple Boosters
8.2.2. Single Booster
8.3. Primary Immunization
8.3.1. Three-Dose Regimen
8.3.2. Two-Dose Regimen
9. DA2PP Vaccine Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.3.1. Manufacturer Portals
9.3.2. Third-Party E Retailers
10. DA2PP Vaccine Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. General Clinics
10.2.2. Pediatric Clinics
10.3. Hospitals
10.4. Pediatric Centers
11. DA2PP Vaccine Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. DA2PP Vaccine Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. DA2PP Vaccine Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. AdvaCare Pharma
15.2. Biogénesis Bagó S.A.
15.3. Biovet Private Ltd.
15.4. Boehringer Ingelheim International GmbH
15.5. Brilliant Bio Pharma Private Limited
15.6. Ceva Santé Animale S.A.
15.7. Colorado Serum Company
15.8. Elanco Animal Health Incorporated
15.9. Hester Biosciences Limited
15.10. Huvepharma AD
15.11. IDT Biologika GmbH
15.12. Indian Immunologicals Limited
15.13. Intas Pharmaceuticals Ltd.
15.14. Laboratorios Hipra S.A.
15.15. Merck & Co. Inc.
15.16. Panav Biotech
15.17. Phibro Animal Health Corporation
15.18. Vetoquinol S.A.
15.19. Virbac S.A.
15.20. Zoetis Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global DA2PP Vaccine Market, Years Considered for the Study
FIGURE 2. Global DA2PP Vaccine Market, Research Design
FIGURE 3. Global DA2PP Vaccine Market, Research Framework
FIGURE 4. Global DA2PP Vaccine Market, Data Triangulation
FIGURE 5. Global DA2PP Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global DA2PP Vaccine Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 7. Global DA2PP Vaccine Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global DA2PP Vaccine Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global DA2PP Vaccine Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global DA2PP Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global DA2PP Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global DA2PP Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global DA2PP Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global DA2PP Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global DA2PP Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global DA2PP Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global DA2PP Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global DA2PP Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global DA2PP Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global DA2PP Vaccine Market Segmentation & Coverage
TABLE 2. Global DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 4. Global Freeze-Dried Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Freeze-Dried Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Freeze-Dried Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Ready To Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Ready To Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Ready To Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Reconstitutable Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Reconstitutable Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Reconstitutable Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 17. Global Booster Immunization Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Booster Immunization Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Booster Immunization Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Multiple Boosters Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Multiple Boosters Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Multiple Boosters Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Single Booster Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Single Booster Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Single Booster Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Primary Immunization Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Primary Immunization Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Primary Immunization Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Three-Dose Regimen Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Three-Dose Regimen Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Three-Dose Regimen Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Two-Dose Regimen Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Two-Dose Regimen Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Two-Dose Regimen Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 36. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Manufacturer Portals Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Manufacturer Portals Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Manufacturer Portals Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Third-Party E Retailers Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Third-Party E Retailers Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Third-Party E Retailers Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 49. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global General Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global General Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global General Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Pediatric Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Pediatric Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Pediatric Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Pediatric Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Pediatric Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Pediatric Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global DA2PP Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific DA2PP Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 75. North America DA2PP Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. North America DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 77. North America DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 78. North America DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. North America DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 80. North America DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 81. North America DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. North America DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 83. North America DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. North America DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 85. Latin America DA2PP Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Latin America DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 87. Latin America DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 88. Latin America DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Latin America DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 90. Latin America DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 91. Latin America DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Latin America DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 93. Latin America DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Latin America DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 95. Europe DA2PP Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Europe DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 97. Europe DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 98. Europe DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Europe DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 100. Europe DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 101. Europe DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 102. Europe DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 103. Europe DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Europe DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 105. Middle East DA2PP Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Middle East DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 107. Middle East DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 108. Middle East DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Middle East DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 110. Middle East DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 111. Middle East DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. Middle East DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 113. Middle East DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Middle East DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 115. Africa DA2PP Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Africa DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 117. Africa DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 118. Africa DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Africa DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 120. Africa DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 121. Africa DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. Africa DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 123. Africa DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Africa DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 125. Global DA2PP Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. ASEAN DA2PP Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. ASEAN DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 128. ASEAN DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 129. ASEAN DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. ASEAN DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 131. ASEAN DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 132. ASEAN DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. ASEAN DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 134. ASEAN DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. ASEAN DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 136. GCC DA2PP Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. GCC DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 138. GCC DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 139. GCC DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. GCC DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 141. GCC DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 142. GCC DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. GCC DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 144. GCC DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. GCC DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 146. European Union DA2PP Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. European Union DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 148. European Union DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 149. European Union DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. European Union DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 151. European Union DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 152. European Union DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. European Union DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 154. European Union DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. European Union DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 156. BRICS DA2PP Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. BRICS DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 158. BRICS DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 159. BRICS DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. BRICS DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 161. BRICS DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 162. BRICS DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. BRICS DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 164. BRICS DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. BRICS DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 166. G7 DA2PP Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. G7 DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 168. G7 DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 169. G7 DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. G7 DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 171. G7 DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 172. G7 DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. G7 DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 174. G7 DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. G7 DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 176. NATO DA2PP Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. NATO DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 178. NATO DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 179. NATO DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. NATO DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 181. NATO DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 182. NATO DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. NATO DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 184. NATO DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. NATO DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 186. Global DA2PP Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. United States DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 188. United States DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 189. United States DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 190. United States DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. United States DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 192. United States DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 193. United States DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. United States DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 195. United States DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. United States DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 197. Canada DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 198. Canada DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 199. Canada DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 200. Canada DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Canada DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 202. Canada DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 203. Canada DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. Canada DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 205. Canada DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Canada DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 207. Mexico DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 208. Mexico DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 209. Mexico DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 210. Mexico DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Mexico DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 212. Mexico DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 213. Mexico DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. Mexico DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 215. Mexico DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Mexico DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 217. Brazil DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 218. Brazil DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 219. Brazil DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 220. Brazil DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. Brazil DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 222. Brazil DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 223. Brazil DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Brazil DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 225. Brazil DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Brazil DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 227. United Kingdom DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 228. United Kingdom DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 229. United Kingdom DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 230. United Kingdom DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. United Kingdom DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 232. United Kingdom DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 233. United Kingdom DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. United Kingdom DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 235. United Kingdom DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. United Kingdom DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 237. Germany DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 238. Germany DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 239. Germany DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 240. Germany DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. Germany DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 242. Germany DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 243. Germany DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Germany DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 245. Germany DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Germany DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 247. France DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 248. France DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 249. France DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 250. France DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. France DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 252. France DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 253. France DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 254. France DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 255. France DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. France DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 257. Russia DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 258. Russia DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 259. Russia DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 260. Russia DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. Russia DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 262. Russia DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 263. Russia DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. Russia DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 265. Russia DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. Russia DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 267. Italy DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 268. Italy DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 269. Italy DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 270. Italy DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. Italy DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 272. Italy DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 273. Italy DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 274. Italy DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 275. Italy DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. Italy DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 277. Spain DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 278. Spain DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 279. Spain DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 280. Spain DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. Spain DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 282. Spain DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 283. Spain DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. Spain DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 285. Spain DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Spain DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 287. China DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 288. China DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 289. China DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 290. China DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. China DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 292. China DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 293. China DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 294. China DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 295. China DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. China DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 297. India DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 298. India DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 299. India DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 300. India DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 301. India DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 302. India DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 303. India DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 304. India DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 305. India DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. India DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 307. Japan DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 308. Japan DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 309. Japan DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 310. Japan DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 311. Japan DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 312. Japan DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 313. Japan DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 314. Japan DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 315. Japan DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. Japan DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 317. Australia DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 318. Australia DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 319. Australia DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 320. Australia DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. Australia DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 322. Australia DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 323. Australia DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 324. Australia DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 325. Australia DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. Australia DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 327. South Korea DA2PP Vaccine Market Size, 2017-2032 (USD Million)
TABLE 328. South Korea DA2PP Vaccine Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 329. South Korea DA2PP Vaccine Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 330. South Korea DA2PP Vaccine Market Size, by Application, 2017-2032 (USD Million)
TABLE 331. South Korea DA2PP Vaccine Market Size, by Booster Immunization, 2017-2032 (USD Million)
TABLE 332. South Korea DA2PP Vaccine Market Size, by Primary Immunization, 2017-2032 (USD Million)
TABLE 333. South Korea DA2PP Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 334. South Korea DA2PP Vaccine Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 335. South Korea DA2PP Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. South Korea DA2PP Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 337. Global DA2PP Vaccine Market Share, by Key Player, 2025
TABLE 338. Global DA2PP Vaccine Market, Key Experts

Companies Mentioned

  • AdvaCare Pharma
  • Biogénesis Bagó S.A.
  • Biovet Private Ltd.
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • Ceva Santé Animale S.A.
  • Colorado Serum Company
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Huvepharma AD
  • IDT Biologika GmbH
  • Indian Immunologicals Limited
  • Intas Pharmaceuticals Ltd.
  • Laboratorios Hipra S.A.
  • Merck & Co. Inc.
  • Panav Biotech
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Related Topics

Related Reports

Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
United States Vaccine Market Report and Forecast 2024-2032 - Product Image

United States Vaccine Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • United States
From
North America Vaccines Market Outlook, 2028 - Product Image

North America Vaccines Market Outlook, 2028

  • Report
  • 101 Pages
  • North America
From
Vaccines Market - Global Forecast 2026-2032 - Product Image

Vaccines Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Vaccine Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Vaccine Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 102 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.